Yeah, this next quarter's earnings might create one last little dip in the chart. I'm not expecting much for the quarter because the company is still investing in developing the DuraMax fiber.
But at $0.66 with book value of $0.44, a P/S under 2, and $0.21/share cash....I wouldn't think there's much further to drop.
Ultimately, I think these prices will prove to be a great entry opportunity......if/when TMED announce they've successfully completed this new fiber for BPH procedures, and/or when Lumenis and Boston Scientific announces they're begining to market it......I imagine TMED could turn right back around and head back towards it's highs.
News 
Market Data 
Discover 
